NACDS chief slams Bush Medicare discount policy process

17 July 2001

As flawed as US President George W Bush's Medicare Prescription DiscountCard Initiative is, the policy process by which it was established is even worse, with White House policy staff "meeting secretly," according to Craig Fuller, president and chief executive of the US National Association of Chain Drug Stores.

"A small band of policy staff needed something to 'get out in front of the debate,' as one aide put it," writes Mr Fuller in his weekly on-line column on www/.monday.morning@nacds.org. "Unfortunately," he added, "they landed on a proposal to discount the value of the pharmacist that many of us could have warned would lead them away from the meaningful Medicare reform and pharmacy benefit for seniors that is of critical importance."

Should this plan ever actually be implemented, he says, the people who will have been given false hope will come to their neighborhood pharmacy to talk with their community pharmacist and find that: there is really no discount on the drug their doctor has prescribed; their pharmacy does not participate in the plan at all; or the plan insists they must accept a different medication to receive a saving.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight